These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 26773278)

  • 1. Prospective association of liver function biomarkers with development of hepatobiliary cancers.
    Stepien M; Fedirko V; Duarte-Salles T; Ferrari P; Freisling H; Trepo E; Trichopoulou A; Bamia C; Weiderpass E; Olsen A; Tjønneland A; Overvad K; Boutron-Ruault MC; Fagherazzi G; Racine A; Kühn T; Kaaks R; Aleksandrova K; Boeing H; Lagiou P; Benetou V; Trichopoulos D; Palli D; Grioni S; Tumino R; Naccarati A; Panico S; Bueno-de-Mesquita HB; Peeters PH; Lund E; Quirós JR; Nápoles OC; Sánchez MJ; Dorronsoro M; Huerta JM; Ardanaz E; Ohlsson B; Sjöberg K; Werner M; Nystrom H; Khaw KT; Key TJ; Gunter M; Cross A; Riboli E; Romieu I; Jenab M
    Cancer Epidemiol; 2016 Feb; 40():179-87. PubMed ID: 26773278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of amino acid and biogenic amine metabolism in hepatobiliary cancers: Findings from a prospective cohort study.
    Stepien M; Duarte-Salles T; Fedirko V; Floegel A; Barupal DK; Rinaldi S; Achaintre D; Assi N; Tjønneland A; Overvad K; Bastide N; Boutron-Ruault MC; Severi G; Kühn T; Kaaks R; Aleksandrova K; Boeing H; Trichopoulou A; Bamia C; Lagiou P; Saieva C; Agnoli C; Panico S; Tumino R; Naccarati A; Bueno-de-Mesquita HB; Peeters PH; Weiderpass E; Quirós JR; Agudo A; Sánchez MJ; Dorronsoro M; Gavrila D; Barricarte A; Ohlsson B; Sjöberg K; Werner M; Sund M; Wareham N; Khaw KT; Travis RC; Schmidt JA; Gunter M; Cross A; Vineis P; Romieu I; Scalbert A; Jenab M
    Int J Cancer; 2016 Jan; 138(2):348-60. PubMed ID: 26238458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer.
    Aleksandrova K; Boeing H; Nöthlings U; Jenab M; Fedirko V; Kaaks R; Lukanova A; Trichopoulou A; Trichopoulos D; Boffetta P; Trepo E; Westhpal S; Duarte-Salles T; Stepien M; Overvad K; Tjønneland A; Halkjaer J; Boutron-Ruault MC; Dossus L; Racine A; Lagiou P; Bamia C; Benetou V; Agnoli C; Palli D; Panico S; Tumino R; Vineis P; Bueno-de-Mesquita B; Peeters PH; Gram IT; Lund E; Weiderpass E; Quirós JR; Agudo A; Sánchez MJ; Gavrila D; Barricarte A; Dorronsoro M; Ohlsson B; Lindkvist B; Johansson A; Sund M; Khaw KT; Wareham N; Travis RC; Riboli E; Pischon T
    Hepatology; 2014 Sep; 60(3):858-71. PubMed ID: 24443059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediagnostic selenium status and hepatobiliary cancer risk in the European Prospective Investigation into Cancer and Nutrition cohort.
    Hughes DJ; Duarte-Salles T; Hybsier S; Trichopoulou A; Stepien M; Aleksandrova K; Overvad K; Tjønneland A; Olsen A; Affret A; Fagherazzi G; Boutron-Ruault MC; Katzke V; Kaaks R; Boeing H; Bamia C; Lagiou P; Peppa E; Palli D; Krogh V; Panico S; Tumino R; Sacerdote C; Bueno-de-Mesquita HB; Peeters PH; Engeset D; Weiderpass E; Lasheras C; Agudo A; Sánchez MJ; Navarro C; Ardanaz E; Dorronsoro M; Hemmingsson O; Wareham NJ; Khaw KT; Bradbury KE; Cross AJ; Gunter M; Riboli E; Romieu I; Schomburg L; Jenab M
    Am J Clin Nutr; 2016 Aug; 104(2):406-14. PubMed ID: 27357089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consumption of soft drinks and juices and risk of liver and biliary tract cancers in a European cohort.
    Stepien M; Duarte-Salles T; Fedirko V; Trichopoulou A; Lagiou P; Bamia C; Overvad K; Tjønneland A; Hansen L; Boutron-Ruault MC; Fagherazzi G; Severi G; Kühn T; Kaaks R; Aleksandrova K; Boeing H; Klinaki E; Palli D; Grioni S; Panico S; Tumino R; Naccarati A; Bueno-de-Mesquita HB; Peeters PH; Skeie G; Weiderpass E; Parr CL; Quirós JR; Buckland G; Molina-Montes E; Amiano P; Chirlaque MD; Ardanaz E; Sonestedt E; Ericson U; Wennberg M; Nilsson LM; Khaw KT; Wareham N; Bradbury KE; Ward HA; Romieu I; Jenab M
    Eur J Nutr; 2016 Feb; 55(1):7-20. PubMed ID: 25528243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating copper and zinc levels and risk of hepatobiliary cancers in Europeans.
    Stepien M; Hughes DJ; Hybsier S; Bamia C; Tjønneland A; Overvad K; Affret A; His M; Boutron-Ruault MC; Katzke V; Kühn T; Aleksandrova K; Trichopoulou A; Lagiou P; Orfanos P; Palli D; Sieri S; Tumino R; Ricceri F; Panico S; Bueno-de-Mesquita HB; Peeters PH; Weiderpass E; Lasheras C; Bonet Bonet C; Molina-Portillo E; Dorronsoro M; Huerta JM; Barricarte A; Ohlsson B; Sjöberg K; Werner M; Shungin D; Wareham N; Khaw KT; Travis RC; Freisling H; Cross AJ; Schomburg L; Jenab M
    Br J Cancer; 2017 Feb; 116(5):688-696. PubMed ID: 28152549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating liver enzymes and risks of chronic diseases and mortality in the prospective EPIC-Heidelberg case-cohort study.
    Katzke V; Johnson T; Sookthai D; Hüsing A; Kühn T; Kaaks R
    BMJ Open; 2020 Mar; 10(3):e033532. PubMed ID: 32152162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of serum aspartate aminotransferase and gamma-glutamyl transpetidase as biomarkers in hepatotoxicity.
    Robles-Diaz M; Garcia-Cortes M; Medina-Caliz I; Gonzalez-Jimenez A; Gonzalez-Grande R; Navarro JM; Castiella A; Zapata EM; Romero-Gomez M; Blanco S; Soriano G; Hidalgo R; Ortega-Torres M; Clavijo E; Bermudez-Ruiz PM; Lucena MI; Andrade RJ; ;
    Liver Int; 2015 Nov; 35(11):2474-82. PubMed ID: 25809419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association of coffee intake with liver cancer risk is mediated by biomarkers of inflammation and hepatocellular injury: data from the European Prospective Investigation into Cancer and Nutrition.
    Aleksandrova K; Bamia C; Drogan D; Lagiou P; Trichopoulou A; Jenab M; Fedirko V; Romieu I; Bueno-de-Mesquita HB; Pischon T; Tsilidis K; Overvad K; Tjønneland A; Bouton-Ruault MC; Dossus L; Racine A; Kaaks R; Kühn T; Tsironis C; Papatesta EM; Saitakis G; Palli D; Panico S; Grioni S; Tumino R; Vineis P; Peeters PH; Weiderpass E; Lukic M; Braaten T; Quirós JR; Luján-Barroso L; Sánchez MJ; Chilarque MD; Ardanas E; Dorronsoro M; Nilsson LM; Sund M; Wallström P; Ohlsson B; Bradbury KE; Khaw KT; Wareham N; Stepien M; Duarte-Salles T; Assi N; Murphy N; Gunter MJ; Riboli E; Boeing H; Trichopoulos D
    Am J Clin Nutr; 2015 Dec; 102(6):1498-508. PubMed ID: 26561631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive analysis of common serum liver enzymes as prospective predictors of hepatocellular carcinoma in HBV patients.
    Hann HW; Wan S; Myers RE; Hann RS; Xing J; Chen B; Yang H
    PLoS One; 2012; 7(10):e47687. PubMed ID: 23112834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating liver function markers and colorectal cancer risk: A prospective cohort study in the UK Biobank.
    He MM; Fang Z; Hang D; Wang F; Polychronidis G; Wang L; Lo CH; Wang K; Zhong R; Knudsen MD; Smith SG; Xu RH; Song M
    Int J Cancer; 2021 Apr; 148(8):1867-1878. PubMed ID: 33091956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of preoperative biliary drainage on liver function changes in patients with malignant obstructive jaundice in the low bile duct before and after pancreaticoduodenectomy].
    Chen D; Liang LJ; Peng BG; Zhou Q; Li SQ; Tang D; Huang L; Huang JF
    Ai Zheng; 2008 Jan; 27(1):78-82. PubMed ID: 18184470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-linear association of liver enzymes with cognitive performance in the elderly: A cross-sectional study.
    Zhang YL; Jia SY; Yang B; Miao J; Su C; Cui ZG; Yang LM; Guo JH
    PLoS One; 2024; 19(7):e0306839. PubMed ID: 39042647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver enzymes and risk of cardiovascular disease in the general population: a meta-analysis of prospective cohort studies.
    Kunutsor SK; Apekey TA; Khan H
    Atherosclerosis; 2014 Sep; 236(1):7-17. PubMed ID: 24998934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated liver enzymes and cardiovascular mortality: a systematic review and dose-response meta-analysis of more than one million participants.
    Rahmani J; Miri A; Namjoo I; Zamaninour N; Maljaei MB; Zhou K; Cerneviciute R; Mousavi SM; Varkaneh HK; Salehisahlabadi A; Zhang Y
    Eur J Gastroenterol Hepatol; 2019 May; 31(5):555-562. PubMed ID: 30614883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of liver function tests in hepatocellular carcinoma.
    Lopez JB; Balasegaram M; Thambyrajah V; Timor J
    Malays J Pathol; 1996 Dec; 18(2):95-9. PubMed ID: 10879229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic dysfunction-associated fatty liver disease and liver function markers are associated with Crohn's disease but not Ulcerative Colitis: a prospective cohort study.
    Chen J; Dan L; Tu X; Sun Y; Deng M; Chen X; Hesketh T; Li R; Wang X; Li X
    Hepatol Int; 2023 Feb; 17(1):202-214. PubMed ID: 36194337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of gamma-glutamyl transpeptidase to alkaline phosphatase ratio combined with gamma-glutamyl transpeptidase to aspartate aminotransferase ratio and alanine aminotransferase to aspartate aminotransferase ratio in alpha-fetoprotein-negative hepatocellular carcinoma.
    Li J; Tao H; Zhang E; Huang Z
    Cancer Med; 2021 Jul; 10(14):4844-4854. PubMed ID: 34145988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic performance of traditional hepatobiliary biomarkers of drug-induced liver injury in the rat.
    Ennulat D; Magid-Slav M; Rehm S; Tatsuoka KS
    Toxicol Sci; 2010 Aug; 116(2):397-412. PubMed ID: 20466777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The associations between liver enzymes and the risk of metabolic syndrome in the elderly.
    Liu CF; Zhou WN; Lu Z; Wang XT; Qiu ZH
    Exp Gerontol; 2018 Jun; 106():132-136. PubMed ID: 29499373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.